Drug profile · INN
zopiclone
IMOVANE
zopiclone (IMOVANE) is a gaba-a receptor; agonist gaba site positive allosteric modulator. Associated with Alphapharm Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — zopiclone
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.81
Quick answer
zopiclone (IMOVANE) is a gaba-a receptor; agonist gaba site positive allosteric modulator. Associated with Alphapharm Pty Ltd.
Key facts
INN zopiclone
Brand IMOVANE
Mechanism GABA-A receptor; agonist GABA site positive allosteric modulator
Target GABA-A receptor; agonist GABA site
Originator Alphapharm Pty Ltd
Mechanism of action
GABA-A receptor; agonist GABA site positive allosteric modulator
Primary target: GABA-A receptor; agonist GABA site
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is zopiclone?
zopiclone (IMOVANE) is a gaba-a receptor; agonist gaba site positive allosteric modulator. Associated with Alphapharm Pty Ltd.
What is the brand name for zopiclone?
IMOVANE is a marketed brand name for zopiclone. Check FDA Drugs@FDA for the current US label holder and prescribing information.